您的位置：山东大学 -> 科技期刊社 -> 《山东大学学报（医学版）》

山东大学学报（医学版） ›› 2016, Vol. 54 ›› Issue (1): 29-32.doi: 10.6040/j.issn.1671-7554.0.2015.413

• 临床医学 • 上一篇    下一篇

影响慢性乙型肝炎病毒感染患者肾功能的危险因素

钱钰,曲云东,王子瑜,刘峰,叶茜,王磊   

  1. 山东大学第二医院肝病科, 山东 济南 250033
  • 收稿日期:2015-04-24 出版日期:2016-01-11 发布日期:2016-01-11
  • 通讯作者: 王磊. E-mail:wlcrb@sdu.edu.cn E-mail:wlcrb@sdu.edu.cn
  • 基金资助:
    艾滋病和病毒性肝炎等重大传染病防治和“十二五”国家科技重大专项(2013ZX10004902);山东省医药卫生科技发展计划(2014WS0424)

Risk factors to influence renal function of patients with chronic hepatitis B virus infection

QIAN Yu, QU Yundong, WANG Ziyu, LIU Feng, YE Qian, WANG Lei   

  1. Department of Hepatology, The Second Hospital of Shandong University, Jinan 250033, Shandong, China
  • Received:2015-04-24 Online:2016-01-11 Published:2016-01-11

PDF (PC)

238

摘要： 目的 分析初治的慢性乙型肝炎病毒(HBV)感染患者的肾功能状况,探讨影响肾功能的危险因素。 方法 连续入组206例慢性HBV感染患者,其中慢性乙型肝炎(CHB)151例,乙型肝炎肝硬化55例,入组患者既往均未接受过抗病毒治疗。应用最新的CKD-EPI方程评估肾小球滤过率估计值(eGFR),评估入组患者肾功能受损［eGFR<90 mL/(min·1.73 m2)］的发生率并分析肾功能异常的危险因素。 结果 206例慢性HBV感染患者中肾功能受损的发生率为21.85%(45/206),CHB和乙型肝炎肝硬化患者肾功能受损发生率分别为17.88%(27/151)和32.73%(18/55),后者明显高于前者(χ2= 5.205, P=0.023)。年龄(≥50岁)及高血压病史为肾功能受损的独立危险因素。 结论 部分慢性HBV感染患者在进行抗病毒治疗前已存在肾功能异常,年龄和高血压病史为肾功能受损的危险因素。对慢性HBV感染患者应进行基线肾功能评估并定期监测肾功能。

关键词: 肾小球滤过率, 肾功能受损, 慢性乙型肝炎

Abstract: Objective To assess the renal function of patients with chronic hepatitis B virus(HBV)infection and to explore the risk factors for renal dysfunction. Methods A total of 206 treatment-naïve patients with chronic HBV infection were enrolled, including 151 cases of chronic hepatitis B(CHB)and 55 cases of liver cirrhosis. The renal function with estimated glomerular filtration rate(eGFR)was calculated with latest Chronic Kidney Disease Epidemiology Collaboration(CKD-EPI)equation. The prevalence of renal impairment ［eGFR < 90 mL/(min·1.73 m2)］ was evaluated and risk factors for renal abnormalities were analyzed. Results The total incidence of renal impairment was 21.85%(45/206), while it was 17.88%(27/151)and 32.73%(18/55)among CHB patients and liver cirrhosis patients, with the latter being significantly higher than the former(χ2= 5.205, P=0.023). Age(≥50 years)and history of hypertension were identified as risk factors for renal impairment. Conclusions Renal abnormalities pre-exist in some patients with chronic HBV infection before the initiation of any antiviral treatment. Age and history of hypertension are identified as risk factors for renal impairment. We need to evaluate renal function in patients with chronic HBV infection at baseline and monitor renal function regularly.

Key words: Glomerular filtration rate, Renal function impairment, Chronic hepatitis B

中图分类号: 

  • R512.6+2
[1] Combes B, Shorey J, Barrera A, et al. Glomerulonephritis with deposition of Australia antigen-antibody complexes in glomerular basement membrane[J]. Lancet, 1971, 2(7718): 234-237.
[2] Zeng CH, Chen HM, Wang RS, et al. Etiology and clinical characteristics of membranous nephropathy in Chinese patients[J]. Am J Kidney Dis, 2008, 52(4): 691-698.
[3] Ha NB, Ha NB, Garcia RT, et al. Renal dysfunction in chronic hepatitis B patients treated with adefovir dipivoxil[J]. Hepatology, 2009, 50(3): 727-734.
[4] Inker LA, Schmid CH, Tighiouart H, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C[J]. N Engl J Med, 2012, 367(1): 20-29.
[5] Inker LA, Astor BC, Fox CH, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD[J]. Am J Kidney Dis, 2014, 63(5): 713-735.
[6] Thyagarajan SP, Thirunalasundari T, Subramanian S, et al. Serum and tissue positivity for hepatitis B virus markers in histopathologically proven glomerulonephropathies[J]. J Med Microbiol, 1989, 29(4): 243-249.
[7] Levey AS, Coresh J, Balk E, et al. National kidney foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification[J]. Ann Intern Med, 2003, 139(2): 137-147.
[8] 钟爱民, 刘燕鸣, 陈红, 等. 血清胱抑素-C是反映肾小球滤过功能的敏感指标[J]. 临床肾脏病杂志, 2004, 4(4): 166-167. ZHONG Aimin, LIU Yanming, CHEN Hong, et al. Serum cystatin C is a sensitive and accurate marker of glomerular filtration rate[J]. J Clin Nephrol, 2004, 4(4):166-167.
[9] Hemmelgarn BR, Manns BJ, Lloyd A, et al. Relation between kidney function, proteinuria, and adverse outcomes[J]. JAMA, 2010, 303(5): 423-429.
[10] 刘红春, 苏利沙, 赵占正, 等. 血清胱抑素C评估慢性肾脏病患者肾小球滤过率的应用研究[J]. 中华检验医学杂志, 2014, 37(3): 184-188. LIU Hongchun, SU Lisha, ZHAO Zhanzheng, et al. The evaluation of glomerular filtration rate in chronic kidney disease patients based on serum CysC[J]. Chin J Lab Med, 2014, 37(3): 184-188.
[11] Mauss S, Berger F, Filmann N, et al. Effect of HBV polymerase inhibitors on renal function in patients with chronic hepatitis B[J]. Hepatol, 2011, 55: 1235-1240.
[12] Amet S, Bronowicki JP, Thabut D, et al. Prevalence of renal abnormalities in chronic HBV infection: The HARPE study[J]. Liver Int, 2015, 35(1): 148-155.
[13] Kim YJ, Cho HC, Sinn DH, et al. Frequency and risk factors of renal impairment during long-term adefovir dipivoxil treatment in chronic hepatitis B patients[J]. J Gastroenterol Hepatol, 2012, 27(2): 306-312.
[14] Tan LK, Gilleece Y, Mandalia S, et al. Reduced glomerular filtration rate but sustained virologic response in HIV/hepatitis B co-infected individuals on long-term tenofovir[J]. J Viral Hepat, 2009, 16(7): 471-478.
[15] 张斌, 万谟彬. 肝肾综合征发病机理[J]. 世界感染杂志, 2002, 2(5-6): 385-387. ZHANG Bin, WAN Mobin. The pathogenesis of hepatorenal syndrome[J]. Infection Journal of the World, 2002, 2(5-6): 385-387.
[16] 刘颖, 樊荣, 陈简, 等. 慢性乙型肝炎病毒感染相关肝硬化患者的肾功能及危险因素分析[J]. 南方医科大学学报, 2014, 34(4): 472-476. LIU Ying, FAN Rong, CHEN Jian, et al. Assessment of renal function and risk factors for renal impairment in patients with hepatitis B virus-related liver cirrhosis[J]. J South Med Univ, 2014, 34(4): 472-476.
[17] Chen N, Wang W, Huang Y, et al. Community-based study on CKD subjects and the associated risk factors[J]. Nephrol Dial Transplant, 2009, 24(7): 2117-2123.
[18] Tanaka M, Suzuki F, Seko Y, et al. Renal dysfunction and hypophosphatemia during long-term lamivudine plus adefovir dipivoxil therapy in patients with chronic hepatitis B[J]. J Gastroenterol, 2014, 49(3): 470-480.
[1] 刘秋霞,王磊,刘峰,曲云东,叶茜,钱钰,张媛,张立新. 慢性HBV感染患者长期服用阿德福韦酯与肾性低磷血症的相关因素[J]. 山东大学学报（医学版）, 2017, 55(7): 73-78.
[2] 张琨,张孝国,崔杏杏,陈士俊. 慢性HBV感染者外周血单个核细胞凋亡相关因子的表达及其与乙肝慢性化的关系[J]. 山东大学学报（医学版）, 2016, 54(7): 38-42.
[3] 欧珠美朵, 嘎松卓嘎, 旦增. 白细胞介素-10基因多态性与西藏地区慢性乙型肝炎的相关性研究[J]. 山东大学学报（医学版）, 2014, 52(S1): 9-9.
[4] 刘同燕1,张龙跃2,李月荣3,孙经利2,韩增禄3,李志荃2,张立新1,王磊1. 干扰素α与阿德福韦酯治疗HBeAg阳性慢性乙型肝炎前瞻性队列观察[J]. 山东大学学报（医学版）, 2014, 52(6): 72-78.
[5] 潘家超1,2，张乐1,2， 徐琳琳3，单晓宇2，杜文军2，陈士俊2. 黑素瘤缺乏因子2诱导的固有免疫在慢性乙型肝炎发病机制中的作用[J]. 山东大学学报（医学版）, 2014, 52(4): 74-79.
[6] 刘伟1，丁艾昆2，李程2，单容3，王昌源1,2. 慢性乙型肝炎疾病进展中瞬时弹性波检测的意义及其影响因素[J]. 山东大学学报（医学版）, 2014, 52(1): 85-88.
[7] 符晓莉，王磊，刘峰. 乙肝病毒感染不同阶段血清HBsAg定量值及其与HBV DNA水平和年龄的相关性[J]. 山东大学学报(医学版), 2013, 51(5): 94-98.
[8] 张秀珍,刘莉,刘倩. 慢性乙型肝炎患者血清瘦素水平与抗病毒治疗应答的相关性[J]. 山东大学学报(医学版), 2012, 50(9): 96-99.
[9] 马敏1,张亮2,邵光峰1,张磊1，刘玉强1. 梗阻性肾病血清中Ⅲ型胶原水平与肾功能改变的相关性研究[J]. 山东大学学报(医学版), 2012, 50(3): 62-65.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
版权所有 © 2018 《山东大学学报(医学版)》编辑部　
地址:山东大学科技期刊社（济南市历城区山大南路27号山东大学中心校区明德楼B座721室） 电话: 0531-88366918 E-mail: xbyxb@sdu.edu.cn
本系统由北京玛格泰克科技发展有限公司设计开发